Connect Biopharma Limite...

AI Score

0

Unlock

1.00
-0.01 (-0.99%)
At close: Jan 28, 2025, 2:14 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -1.09 -0.41 -1.31 -8.29 -42.96 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 0.64 -0.1 0.99 -6.35 -23.85 n/a
P/FCF Ratio -1.35 -0.46 -2.89 -35.68 -77.89 n/a
P/OCF Ratio -1.36 -0.48 -3.15 -38.95 -78.82 n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.00 -0.00 0.00 -0.00 -0.00 -4.52
Quick Ratio 4.99 10.37 15.30 26.97 12.44 70.44
Current Ratio 4.99 9.97 15.30 27.81 13.24 70.44
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -5.59K -14.35K -4.71K -2.08K n/a
Return on Equity (ROE) -0.59 0.25 -0.75 0.77 0.56 n/a
Return on Assets (ROA) -0.47 -0.66 -0.7 -0.72 -0.44 n/a
Return on Capital (ROIC) -0.61 -0.73 -0.36 -0.19 -0.32 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a